Mark Edward Van Wormer, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 314 N 3rd Ave, Clayton, NM 88415 Phone: 575-374-8313 Fax: 575-374-2064 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented positive preliminary data from fully monitored study data for the entire study population of 80 subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma.
Physicians now have access to an even faster and more accurate handheld ultrasound device, with Signostics today unveiling its new "Signos RT" model.
The National African American Tobacco Prevention Network has denounced a plan by KOOL brand cigarettes to escalate its targeting of black youth and urban hip-hop culture by sponsoring a nationwide Hip-Hop DJ Competition
Researchers at MIT's research center in Singapore have developed a new microfluidic device that tests the effects of electric fields on cancer cells.
Bellicum Pharmaceuticals, Inc. today announced $4.5 million in Series A and Convertible Note funding. The new funds will be used to complete the company's ongoing Phase I/IIa trial of BP-GMAX-CD1 in patients with advanced, androgen independent prostate cancer, and to prepare for Phase IIb trials. The company anticipates reporting initial results of the Phase I/IIa trial in mid 2010.
› Verified 7 days ago